Hormone replacement therapy linked to increased risk of ovarian cancer, study finds An analysis of over 50 studies suggests an association between short-term use of hormone replacement therapy (HRT) during menopause and a 40 percent increased risk of developing ovarian cancer.
New test can determine effectiveness of cancer treatment within 16 hours Researchers at Dana Farber Cancer Institute in Boston have developed a new technique that can predict which specific drug will be most effective in treating various types of cancer tumors.
Tomato-rich diet found to lower risk of prostate cancer, study says When it comes to staying prostate-cancer free, there's nothing like a routine checkup at the doctor's office ... or, easier yet, some tomatoes.
6 ways to heal sun-damaged skin The sun’s rays can wreak havoc on your skin, causing fine lines and wrinkles, uneven skin, broken blood vessels, sun spots, and even worse, skin cancer.
Do fish oil supplements really increase prostate cancer risk? Fish oil supplements have been shown to provide a variety of benefits when it comes to cardiovascular health, but is there a down side to taking them?
Common cold virus could help treat cancer Clinical trial underway testing viral therapy on pancreatic cancer.
Colon cancer rates declining The incidence of colon cancer, declining since the mid-1980s, plunged a further 30 percent last decade among Americans 50 and older as more people had colonoscopies, a new study found.
Bristol's Opdivo boosts kidney cancer survival beyond 2 years Bristol-Myers Squibb's immunotherapy drug Opdivo extended kidney cancer survival rates by more than two years in a late-stage trial, setting it up to be used beyond melanoma and lung cancer.
Some leukemia patients see durable results from Novartis therapy Some leukemia patients who had exhausted other treatment options have no trace of the disease more than four years after being treated with an experimental type of therapy called CAR T cells in a small pilot study at the University of Pennsylvania.
Testing for more breast cancer genes offers useful information When the results of a test wouldn’t change how doctors manage a patient’s care, most say it’s not worth doing. But new tests for breast cancer risk mutations beyond the well-known BRCA genes would offer actionable information for many women and their doctors, a new study finds.
